Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma
Clinical trial NCT04910594 · UNKNOWN
Trial details
- NCT number
- NCT04910594
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-02-14
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.